A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02

NCT00583362 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

298

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: Belimumab

Sponsor

Human Genome Sciences Inc., a GSK Company

Collaborators

[object Object]